Article Data

  • Views 541
  • Dowloads 121

Original Research

Open Access

PTEN and CD146 expression in endometrioid adenocarcinoma

  • Q. Huang1
  • Y. He2
  • X. Cao2
  • C. Yi2,*,

1Department of Gynecology and Obstetrics, Wuhan Asia General Hospital, Wuhan 430000, China

2Department of Gynecology and Obstetrics, the First Affiliated Hospital of Yangzte University, Jingzhou 434000, China

DOI: 10.31083/j.ejgo.2020.03.5051 Vol.41,Issue 3,June 2020 pp.439-443

Submitted: 10 October 2018 Accepted: 10 January 2019

Published: 15 June 2020

*Corresponding Author(s): C. Yi E-mail:


Objective: Endometrioid adenocarcinoma is the most common pathological type of endometrial carcinoma. This study aimed to examine the expression of PTEN and CD146 in endometrioid adenocarcinoma, and to investigate their relationship with clinical characteristics of endometrioid adenocarcinoma. Materials and Methods: The expression of PTEN and CD146 in 126 specimens of endometrioid adenocarcinoma was detected by immunohistochemical technique, and the correlation of their expression with clinical parameters of the patients was analyzed. Results: PTEN expression in endometrioid adenocarcinoma group was lower than that in endometrial hyperplasia group and endometrial polyp group, while CD146 expression in endometrioid adenocarcinoma group was higher than that in endometrial hyperplasia group and endometrial polyp group (p < 0.05). High expression of CD146 was associated with his tological grade and depth of invasion of endometrioid adenocarcinoma, but there was no correlation between PTEN expression and clinical parameters. Conclusions: CD146 and PTEN may be promising biomarkers and targets for the diagnosis and treatment of endometrioid adenocarcinoma.


Endometrioid adenocarcinoma; PTEN; CD146; Pathology

Cite and Share

Q. Huang,Y. He,X. Cao,C. Yi. PTEN and CD146 expression in endometrioid adenocarcinoma. European Journal of Gynaecological Oncology. 2020. 41(3);439-443.


[1] Morice P., Leary A., Creutzberg C., Abu-Rustum N., Darai E.: “Endometrial cancer”. Lancet, 2016, 387, 1094.

[2] Hakim S.A., Raboh N.M.: “Immunohistochemical expression of glypican 3 in endometrial carcinoma and correlation with prognostic parameters”. Int. J. Clin. Exp. Pathol., 2015, 8, 13225.

[3] Wang Y., Mang M., Wang Y., Wang L., Klein R., Kong B., Zheng W.: “Tubal origin of ovarian endometriosis and clear cell and endometrioid carcinoma”. Am. J. Cancer Res., 2015, 5, 869.

[4] Makker A., Goel M.M.: “Tumor progression, metastasis, and modulators of epithelial-mesenchymal transition in endometrioid endometrial carcinoma: an update”. Endocr. Relat. Cancer, 2016, 23, R85.

[5] Arik D., Kabukcuoglu S.: “CDX2 expression in endometrial endometrioid adenocarcinoma”. Eur. J. Gynaecol. Oncol., 2017, 38, 704.

[6] Silva J.L., Paulino E., Dias M.F., Melo A.C.: “Endometrial cancer: redefining the molecular-targeted approach”. Cancer Chemother. Pharmacol., 2015, 76, 1.

[7] Lei X., Guan C.W., Song Y., Wang H.: “The multifaceted role of CD146/MCAM in the promotion of melanoma progression”. Cancer Cell Int., 2015, 15, 3.

[8] Jiang G., Zhang L., Zhu Q., Bai D., Zhang C., Wang X.: “CD146 promotes metastasis and predicts poor prognosis of hepatocellular carcinoma”. J. Exp. Clin. Cancer Res., 2016, 35, 38.

[9] Jouve N., Bachelier R., Despoix N., Blin M.G., Matinzadeh M.K., Poitevin S., et al.: “CD146 mediates VEGF-induced melanoma cell extravasation through FAK activation. Int J Cancer 2015; 137: 50- 60.

[10] Kristiansen G, Yu Y, Schluns K, Sers C, Dietel M, Petersen I. Expression of the cell adhesion molecule CD146/MCAM in non-small cell lung cancer”. Anal. Cell Pathol., 2003, 25, 77.

[11] Latta E., Chapman W.B.: “PTEN mutations and evolving concepts in endometrial neoplasia”. Curr. Opin. Obstet. Gynecol., 2002, 14, 59.

[12] Yang M.F., Lou Y.L., Liu S.S., Wang S.S., Yin C.H., Cheng X.H., Huang O.P.: “Capn4 overexpression indicates poor prognosis of ovarian cancer patients”. J. Cancer, 2018, 9, 304.

[13] Correa D., Somoza R.A., Lin P., Schiemann W.P., Caplan A.I.: “Mesenchymal stem cells regulate melanoma cancer cells extravasation to bone and liver at their perivascular niche”. Int. J. Cancer, 2016, 138, 417.

[14] Najjar F., Al-Massarani G., Banat I., Alammar M.: “Circulating endothelial cells for evaluation of tumor response in non-small cell lung cancer patients receiving first-line chemotherapy”. Int. J. Biol. Markers, 2015, 30, e374.

[15] Wang Z., Yan X.: “CD146, a multi-functional molecule beyond adhesion”. Cancer Lett., 2013, 330, 150.

[16] Westrøm S., Bønsdorff T.B., Abbas N., Bruland Ø.S., Jonasdottir T.J., Mælandsmo G.M., Larsen R.H.: “Evaluation of CD146 as target for radioimmunotherapy against osteosarcoma”. PLoS One, 2016, 11, 0165382.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time